Fujifilm Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Inventeur(s)
Mulvihill, Daniel
Baker, Karen
Eastwood, Tara
Lennon, Christopher
Abrégé
Described is a method and component parts of a recombinant expression system for the expression of a biological molecule. In particular, an isolated vesicle nucleating polypeptide (VNp) comprising an amphipathic alpha helix polypeptide derived from the amino terminus of synuclein isoforms and variants thereof is used to promote, enhance or increase the formation of vesicles in the expression system to enable purification of the biological molecule.
C12P 21/00 - Préparation de peptides ou de protéines
C07K 14/47 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'animauxPeptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'humains provenant de vertébrés provenant de mammifères
C12N 15/62 - Séquences d'ADN codant pour des protéines de fusion
C12N 15/70 - Vecteurs ou systèmes d'expression spécialement adaptés à E. coli
37 - Services de construction; extraction minière; installation et réparation
40 - Traitement de matériaux; recyclage, purification de l'air et traitement de l'eau
42 - Services scientifiques, technologiques et industriels, recherche et conception
Produits et services
Construction services; building services; construction of
pharmaceutical facilities; onsite management relating to the
construction of pharmaceutical manufacturing facilities;
building and construction of factories; custom construction
of factories and pharmaceutical manufacturing facilities;
information, advice and consultancy in relation to all the
aforesaid. Custom processing and manufacturing services; custom
processing and manufacturing of pharmaceuticals; custom
manufacture of pharmaceuticals; manufacture, processing and
production of recombinant proteins for use in the
biotechnology industries to the order and specification of
others; cell culture manufacturing services for others;
custom manufacture of biologics; information, advice and
consultancy in relation to all the aforesaid. Scientific and technological services; research and
development; scientific, industrial and technical research,
development and analysis services; scientific, industrial
and technical research, development and analysis services in
the field of biotechnology; process development (term
considered too vague by the International Bureau pursuant to
Rule 13 (2) (b) of the Regulations); development of
processes for the use in the manufacture of biotechnology
products; project studies (term considered too vague by the
International Bureau pursuant to Rule 13 (2) (b) of the
Regulations); biotechnology testing; research and
consultancy in the field of biotechnology; research and
development in the pharmaceutical and biotechnology
industry; scientific, technological and pharmaceutical
process development and design; biopharmaceutical product
development; software development, programming and
implementation; design and development of software; design
and development of manufacturing processes in the field of
biopharmaceuticals; design of manufacturing methods; design
of industrial buildings; design of manufacturing plants;
engineering services; research laboratories; preparations of
biological samples for analysis in research laboratories
(term considered linguistically incorrect by the
International Bureau pursuant to Rule 13 (2) (b) of the
Regulations); designs services relating to process systems
for the biotechnology industry; design services relating to
plant for the biotechnology industry; information, advice
and consultancy in relation to all the aforesaid.
37 - Services de construction; extraction minière; installation et réparation
40 - Traitement de matériaux; recyclage, purification de l'air et traitement de l'eau
42 - Services scientifiques, technologiques et industriels, recherche et conception
Produits et services
Construction services; building services; construction of
pharmaceutical facilities; onsite management relating to the
construction of pharmaceutical manufacturing facilities;
building and construction of factories; custom construction
of factories and pharmaceutical manufacturing facilities;
information, advice and consultancy in relation to all the
aforesaid. Custom processing and manufacturing services; custom
processing and manufacturing of pharmaceuticals; custom
manufacture of pharmaceuticals; manufacture, processing and
production of recombinant proteins for use in the
biotechnology industries to the order and specification of
others; cell culture manufacturing services for others;
custom manufacture of biologics; information, advice and
consultancy in relation to all the aforesaid. Scientific and technological services; research and
development; scientific, industrial and technical research,
development and analysis services; scientific, industrial
and technical research, development and analysis services in
the field of biotechnology; industrial process development;
development of processes for the use in the manufacture of
biotechnology products; technical project studies;
biotechnology testing; research and consultancy in the field
of biotechnology; research and development in the
pharmaceutical and biotechnology industry; scientific,
technological and pharmaceutical process development and
design; biopharmaceutical product development; software
development, programming and implementation; design and
development of software; design and development of
manufacturing processes in the field of biopharmaceuticals;
design of manufacturing methods; design of industrial
buildings; design of manufacturing plants; engineering
services; research laboratories; preparations of biological
samples for analysis in research laboratories; designs
services relating to process systems for the biotechnology
industry; design services relating to plant for the
biotechnology industry; information, advice and consultancy
in relation to all the aforesaid.
01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
40 - Traitement de matériaux; recyclage, purification de l'air et traitement de l'eau
42 - Services scientifiques, technologiques et industriels, recherche et conception
Produits et services
Cell cultures used in industry and science; mammalian cell
cultures and vectors, being independent replicating pieces
of DNA that can transfer DNA sequences, each for manufacture
and development in the biotechnology industries; biological
preparations for use in science; biological preparations for
use in cell cultures; cell culture reagents for scientific
and research use; media for cell culture for use in the
biotechnological industry; chemical products for
biotechnological purposes; chemicals for use in
biotechnological manufacturing processes. Processing and manufacturing of vectors, cell cultures and
recombinant proteins for use in biotechnology industries to
the order and specification of others; manufacture,
processing and production of recombinant proteins for use in
the biotechnology industries to the order and specification
of others; custom processing and manufacturing services in
the field of biopharmaceuticals; custom processing and
manufacturing of biological products; custom manufacture of
biopharmaceuticals; cell culture manufacturing services for
others; custom manufacture of biologics; information, advice
and consultancy in relation to all the aforesaid. Scientific, industrial and technical research, development
and analysis services; development and analysis services
relating to the use of mammalian cell cultures and vectors
in the field of biotechnology; biotechnology process
development; development of processes for the use of
mammalian cell cultures and vectors in the manufacture of
biotechnology products; technical project studies; project
studies relating to the use of mammalian cell cultures and
vectors in the field of biotechnology; development of
processes for the use in the manufacture of biotechnology
products; technical project studies; biotechnology testing;
research and consultancy in the field of biotechnology;
research and development in the pharmaceutical and
biotechnology industry; scientific, technological and
pharmaceutical process development and design;
biopharmaceutical product development; design and
development of manufacturing processes in the field of
biopharmaceuticals; development of chemicals for use in the
manufacture of biotechnology products and pharmaceuticals;
preparation of biological samples for analysis in research
laboratories; information, advice and consultancy in
relation to all the aforesaid.
37 - Services de construction; extraction minière; installation et réparation
40 - Traitement de matériaux; recyclage, purification de l'air et traitement de l'eau
42 - Services scientifiques, technologiques et industriels, recherche et conception
Produits et services
Construction services; building services; construction of
pharmaceutical facilities; onsite management relating to the
construction of pharmaceutical manufacturing facilities;
building and construction of factories; custom construction
of factories and pharmaceutical manufacturing facilities;
information, advice and consultancy in relation to all the
aforesaid. Custom processing and manufacturing services; custom
processing and manufacturing of pharmaceuticals; custom
manufacture of pharmaceuticals; manufacture, processing and
production of recombinant proteins for use in the
biotechnology industries to the order and specification of
others; cell culture manufacturing services for others;
custom manufacture of biologics; information, advice and
consultancy in relation to all the aforesaid. Scientific and technological services; research and
development; scientific, industrial and technical research,
development and analysis services; scientific, industrial
and technical research, development and analysis services in
the field of biotechnology; industrial process development;
development of processes for the use in the manufacture of
biotechnology products; technical project studies;
biotechnology testing; research and consultancy in the field
of biotechnology; research and development in the
pharmaceutical and biotechnology industry; scientific,
technological and pharmaceutical process development and
design; biopharmaceutical product development; software
development, programming and implementation; design and
development of software; design and development of
manufacturing processes in the field of biopharmaceuticals;
design of manufacturing methods; design of industrial
buildings; design of manufacturing plants; engineering
services; research laboratories; preparation of biological
samples for analysis in research laboratories; designs
services relating to process systems for the biotechnology
industry; design services relating to plant for the
biotechnology industry; information, advice and consultancy
in relation to all the aforesaid.
01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
40 - Traitement de matériaux; recyclage, purification de l'air et traitement de l'eau
42 - Services scientifiques, technologiques et industriels, recherche et conception
Produits et services
Chemicals used in industry and science; cell cultures used
in industry and science; biological preparations for use in
science; biological preparations for use in cell cultures;
proteins for use in industry, enzymes; microbial
preparations being chemicals for industry; cultures of
micro-organisms other than for medical or veterinary use;
chemical reagents; organic chemicals for use in science,
namely genes being DNA sequences; plasmids being small
independently replicating pieces of DNA and vectors being
small independently replicating pieces of DNA that can
transfer DNA sequences, being chemicals for use in science;
cell culture reagents for scientific and research use; media
for cell culture for use in the biotechnological industry;
chemical products for biotechnological purposes; chemicals
for use in biotechnological manufacturing processes. Processing and manufacturing of chemicals and proteins;
custom manufacture of chemicals and proteins for use in
biotechnology and pharmaceuticals; manufacture, processing
and production of scientific and industrial products to the
order and specification of others; custom processing and
manufacturing services; custom processing and manufacturing
of biological products; custom manufacture of
biopharmaceuticals; manufacture, processing and production
of recombinant proteins for use in the biotechnology
industries to the order and specification of others; cell
culture manufacturing services for others; custom
manufacture of biologics; information, advice and
consultancy in relation to all the aforesaid. Scientific, industrial and technical research; scientific
analysis; technological analysis services; scientific
research and development; industrial process development;
industrial design services; provision of facilities for
scientific, industrial and technical research and
development; research and development of scientific,
industrial and technical products; technical project
studies; testing of scientific, industrial and technical
products; scientific, industrial and technical research,
development and analysis services in the field of
biotechnology; development of processes for the use in the
manufacture of biotechnology products; project studies;
biotechnology testing; research and consultancy in the field
of biotechnology; research and development in the
pharmaceutical and biotechnology industry; scientific,
technological and pharmaceutical process development and
design; biopharmaceutical product development; design and
development of manufacturing processes in the field of
biopharmaceuticals; development of chemicals for use in the
manufacture of biotechnology products and pharmaceuticals;
preparation of biological samples for analysis in research
laboratories; information, advice and consultancy in
relation to all the aforesaid.
01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
40 - Traitement de matériaux; recyclage, purification de l'air et traitement de l'eau
42 - Services scientifiques, technologiques et industriels, recherche et conception
Produits et services
Cell cultures used in industry and science; mammalian cell
cultures and vectors, being independent replicating pieces
of DNA that can transfer DNA sequences, each for manufacture
and development in the biotechnology industries; biological
preparations for use in science; biological preparations for
use in cell cultures; cell culture reagents for scientific
and research use; media for cell culture for use in the
biotechnological industry; chemical products for
biotechnological purposes; chemicals for use in
biotechnological manufacturing processes. Processing and manufacturing of vectors, cell cultures and
recombinant proteins for use in biotechnology industries to
the order and specification of others; manufacture,
processing and production of recombinant proteins for use in
the biotechnology industries to the order and specification
of others; custom processing and manufacturing services;
custom processing and manufacturing of biological products;
custom manufacture of biopharmaceuticals; cell culture
manufacturing services for others; custom manufacture of
biologics; information, advice and consultancy in relation
to all the aforesaid. Scientific, industrial and technical research, development
and analysis services; development and analysis services
relating to the use of mammalian cell cultures and vectors
in the field of biotechnology; industrial process
development; development of processes for the use of
mammalian cell cultures and vectors in the manufacture of
biotechnology products; technical project studies; project
studies relating to the use of mammalian cell cultures and
vectors in the field of biotechnology; development of
processes for the use in the manufacture of biotechnology
products; technical project studies; biotechnology testing;
research and consultancy in the field of biotechnology;
research and development in the pharmaceutical and
biotechnology industry; scientific, technological and
pharmaceutical process development and design;
biopharmaceutical product development; design and
development of manufacturing processes in the field of
biopharmaceuticals; development of chemicals for use in the
manufacture of biotechnology products and pharmaceuticals;
preparation of biological samples for analysis in research
laboratories; information, advice and consultancy in
relation to all the aforesaid.
37 - Services de construction; extraction minière; installation et réparation
40 - Traitement de matériaux; recyclage, purification de l'air et traitement de l'eau
42 - Services scientifiques, technologiques et industriels, recherche et conception
Produits et services
Construction services; building services; construction of
pharmaceutical facilities; onsite management relating to the
construction of pharmaceutical manufacturing facilities;
building and construction of factories; custom construction
of factories and pharmaceutical manufacturing facilities;
information, advice and consultancy in relation to all the
aforesaid. Custom processing and manufacturing services; custom
processing and manufacturing of pharmaceuticals; custom
manufacture of pharmaceuticals; manufacture, processing and
production of recombinant proteins for use in the
biotechnology industries to the order and specification of
others; cell culture manufacturing services for others;
custom manufacture of biologics; information, advice and
consultancy in relation to all the aforesaid. Scientific and technological services; research and
development; scientific, industrial and technical research,
development and analysis services; scientific, industrial
and technical research, development and analysis services in
the field of biotechnology; industrial process development;
development of processes for the use in the manufacture of
biotechnology products; technical project studies;
biotechnology testing; research and consultancy in the field
of biotechnology; research and development in the
pharmaceutical and biotechnology industry; scientific,
technological and pharmaceutical process development and
design; biopharmaceutical product development; software
development, programming and implementation; design and
development of software; design and development of
manufacturing processes in the field of biopharmaceuticals;
design of manufacturing methods; design of industrial
buildings; design of manufacturing plants; engineering
services; research laboratories; preparation of biological
samples for analysis in research laboratories; designs
services relating to process systems for the biotechnology
industry; design services relating to plant for the
biotechnology industry; information, advice and consultancy
in relation to all the aforesaid.
01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
40 - Traitement de matériaux; recyclage, purification de l'air et traitement de l'eau
42 - Services scientifiques, technologiques et industriels, recherche et conception
Produits et services
Cell cultures used in industry and science; mammalian cell cultures and vectors, being independent replicating pieces of DNA that can transfer DNA sequences, each for manufacture and development in the biotechnology industries; biological preparations for use in science; biological preparations for use in cell cultures; cell culture reagents for scientific and research use; media for cell culture for use in the biotechnological industry; chemical products for biotechnological purposes; chemicals for use in biotechnological manufacturing processes. Processing and manufacturing of vectors, cell cultures and recombinant proteins for use in biotechnology industries to the order and specification of others; manufacture, processing and production of recombinant proteins for use in the biotechnology industries to the order and specification of others; custom processing and manufacturing services; custom processing and manufacturing of biological products; custom manufacture of biopharmaceuticals; cell culture manufacturing services for others; custom manufacture of biologics; information, advice and consultancy in relation to all the aforesaid. Scientific, industrial and technical research, development and analysis services; development and analysis services relating to the use of mammalian cell cultures and vectors in the field of biotechnology; industrial process development; development of processes for the use of mammalian cell cultures and vectors in the manufacture of biotechnology products; technical project studies; project studies relating to the use of mammalian cell cultures and vectors in the field of biotechnology; development of processes for the use in the manufacture of biotechnology products; technical project studies; biotechnology testing; research and consultancy in the field of biotechnology; research and development in the pharmaceutical and biotechnology industry; scientific, technological and pharmaceutical process development and design; biopharmaceutical product development; design and development of manufacturing processes in the field of biopharmaceuticals; development of chemicals for use in the manufacture of biotechnology products and pharmaceuticals; preparation of biological samples for analysis in research laboratories; information, advice and consultancy in relation to all the aforesaid.
01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
40 - Traitement de matériaux; recyclage, purification de l'air et traitement de l'eau
42 - Services scientifiques, technologiques et industriels, recherche et conception
Produits et services
Chemicals used in industry and science; cell cultures used in industry and science; biological preparations for use in science; biological preparations for use in cell cultures; proteins for use in industry, enzymes; microbial preparations being chemicals for industry; cultures of micro-organisms other than for medical or veterinary use; chemical reagents; organic chemicals for use in science, namely genes being DNA sequences; plasmids being small independently replicating pieces of DNA and vectors being small independently replicating pieces of DNA that can transfer DNA sequences, being chemicals for use in science; cell culture reagents for scientific and research use; media for cell culture for use in the biotechnological industry; chemical products for biotechnological purposes; chemicals for use in biotechnological manufacturing processes. Processing and manufacturing of chemicals and proteins; custom manufacture of chemicals and proteins for use in biotechnology and pharmaceuticals; manufacture, processing and production of scientific and industrial products to the order and specification of others; custom processing and manufacturing services; custom processing and manufacturing of biological products; custom manufacture of biopharmaceuticals; manufacture, processing and production of recombinant proteins for use in the biotechnology industries to the order and specification of others; cell culture manufacturing services for others; custom manufacture of biologics; information, advice and consultancy in relation to all the aforesaid. Scientific, industrial and technical research; scientific analysis; technological analysis services; scientific research and development; industrial process development; industrial design services; provision of facilities for scientific, industrial and technical research and development; research and development of scientific, industrial and technical products; technical project studies; testing of scientific, industrial and technical products; scientific, industrial and technical research, development and analysis services in the field of biotechnology; development of processes for the use in the manufacture of biotechnology products; project studies; biotechnology testing; research and consultancy in the field of biotechnology; research and development in the pharmaceutical and biotechnology industry; scientific, technological and pharmaceutical process development and design; biopharmaceutical product development; design and development of manufacturing processes in the field of biopharmaceuticals; development of chemicals for use in the manufacture of biotechnology products and pharmaceuticals; preparation of biological samples for analysis in research laboratories; information, advice and consultancy in relation to all the aforesaid.
40 - Traitement de matériaux; recyclage, purification de l'air et traitement de l'eau
37 - Services de construction; extraction minière; installation et réparation
42 - Services scientifiques, technologiques et industriels, recherche et conception
Produits et services
Custom processing and manufacturing services; custom processing and manufacturing of pharmaceuticals; custom manufacture of pharmaceuticals; manufacture, processing and production of recombinant proteins for use in the biotechnology industries to the order and specification of others; cell culture manufacturing services for others; custom manufacture of biologics; information, advice and consultancy in relation to all the aforesaid. Construction services; building services; construction of pharmaceutical facilities; onsite management relating to the construction of pharmaceutical manufacturing facilities; building and construction of factories; custom construction of factories and pharmaceutical manufacturing facilities; information, advice and consultancy in relation to all the aforesaid. Scientific and technological services; research and development; scientific, industrial and technical research, development and analysis services; scientific, industrial and technical research, development and analysis services in the field of biotechnology; industrial process development; development of processes for the use in the manufacture of biotechnology products; technical project studies; biotechnology testing; research and consultancy in the field of biotechnology; research and development in the pharmaceutical and biotechnology industry; scientific, technological and pharmaceutical process development and design; biopharmaceutical product development; software development, programming and implementation; design and development of software; design and development of manufacturing processes in the field of biopharmaceuticals; design of manufacturing methods; design of industrial buildings; design of manufacturing plants; engineering services; research laboratories; preparation of biological samples for analysis in research laboratories; designs services relating to process systems for the biotechnology industry; design services relating to plant for the biotechnology industry; information, advice and consultancy in relation to all the aforesaid.
01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
40 - Traitement de matériaux; recyclage, purification de l'air et traitement de l'eau
42 - Services scientifiques, technologiques et industriels, recherche et conception
Produits et services
Cell cultures used in industry and science; mammalian cell cultures and vectors, being independent replicating pieces of DNA that can transfer DNA sequences, each for manufacture and development in the biotechnology industries; biological preparations for use in science; biological preparations for use in cell cultures; cell culture reagents for scientific and research use; media for cell culture for use in the biotechnological industry; chemical products for biotechnological purposes; chemicals for use in biotechnological manufacturing processes. Processing and manufacturing of vectors, cell cultures and recombinant proteins for use in biotechnology industries to the order and specification of others; manufacture, processing and production of recombinant proteins for use in the biotechnology industries to the order and specification of others; custom processing and manufacturing services in the field of biopharmaceuticals; custom processing and manufacturing of biological products; custom manufacture of biopharmaceuticals; cell culture manufacturing services for others; custom manufacture of biologics; information, advice and consultancy in relation to all the aforesaid. Scientific, industrial and technical research, development and analysis services; development and analysis services relating to the use of mammalian cell cultures and vectors in the field of biotechnology; biotechnology process development; development of processes for the use of mammalian cell cultures and vectors in the manufacture of biotechnology products; technical project studies; project studies relating to the use of mammalian cell cultures and vectors in the field of biotechnology; development of processes for the use in the manufacture of biotechnology products; technical project studies; biotechnology testing; research and consultancy in the field of biotechnology; research and development in the pharmaceutical and biotechnology industry; scientific, technological and pharmaceutical process development and design; biopharmaceutical product development; design and development of manufacturing processes in the field of biopharmaceuticals; development of chemicals for use in the manufacture of biotechnology products and pharmaceuticals; preparation of biological samples for analysis in research laboratories; information, advice and consultancy in relation to all the aforesaid.
40 - Traitement de matériaux; recyclage, purification de l'air et traitement de l'eau
37 - Services de construction; extraction minière; installation et réparation
42 - Services scientifiques, technologiques et industriels, recherche et conception
Produits et services
Custom processing and manufacturing services; custom processing and manufacturing of pharmaceuticals; custom manufacture of pharmaceuticals; manufacture, processing and production of recombinant proteins for use in the biotechnology industries to the order and specification of others; cell culture manufacturing services for others; custom manufacture of biologics; information, advice and consultancy in relation to all the aforesaid. Construction services; building services; construction of pharmaceutical facilities; onsite management relating to the construction of pharmaceutical manufacturing facilities; building and construction of factories; custom construction of factories and pharmaceutical manufacturing facilities; information, advice and consultancy in relation to all the aforesaid. Scientific and technological services; research and development; scientific, industrial and technical research, development and analysis services; scientific, industrial and technical research, development and analysis services in the field of biotechnology; process development (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); development of processes for the use in the manufacture of biotechnology products; project studies (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); biotechnology testing; research and consultancy in the field of biotechnology; research and development in the pharmaceutical and biotechnology industry; scientific, technological and pharmaceutical process development and design; biopharmaceutical product development; software development, programming and implementation; design and development of software; design and development of manufacturing processes in the field of biopharmaceuticals; design of manufacturing methods; design of industrial buildings; design of manufacturing plants; engineering services; research laboratories; preparations of biological samples for analysis in research laboratories (term considered linguistically incorrect by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); designs services relating to process systems for the biotechnology industry; design services relating to plant for the biotechnology industry; information, advice and consultancy in relation to all the aforesaid.
40 - Traitement de matériaux; recyclage, purification de l'air et traitement de l'eau
37 - Services de construction; extraction minière; installation et réparation
42 - Services scientifiques, technologiques et industriels, recherche et conception
Produits et services
Custom processing and manufacturing services; custom processing and manufacturing of pharmaceuticals; custom manufacture of pharmaceuticals; manufacture, processing and production of recombinant proteins for use in the biotechnology industries to the order and specification of others; cell culture manufacturing services for others; custom manufacture of biologics; information, advice and consultancy in relation to all the aforesaid. Construction services; building services; construction of pharmaceutical facilities; onsite management relating to the construction of pharmaceutical manufacturing facilities; building and construction of factories; custom construction of factories and pharmaceutical manufacturing facilities; information, advice and consultancy in relation to all the aforesaid. Scientific and technological services; research and development; scientific, industrial and technical research, development and analysis services; scientific, industrial and technical research, development and analysis services in the field of biotechnology; industrial process development; development of processes for the use in the manufacture of biotechnology products; technical project studies; biotechnology testing; research and consultancy in the field of biotechnology; research and development in the pharmaceutical and biotechnology industry; scientific, technological and pharmaceutical process development and design; biopharmaceutical product development; software development, programming and implementation; design and development of software; design and development of manufacturing processes in the field of biopharmaceuticals; design of manufacturing methods; design of industrial buildings; design of manufacturing plants; engineering services; research laboratories; preparation of biological samples for analysis in research laboratories; designs services relating to process systems for the biotechnology industry; design services relating to plant for the biotechnology industry; information, advice and consultancy in relation to all the aforesaid.
40 - Traitement de matériaux; recyclage, purification de l'air et traitement de l'eau
37 - Services de construction; extraction minière; installation et réparation
42 - Services scientifiques, technologiques et industriels, recherche et conception
Produits et services
Custom processing and manufacturing services; custom processing and manufacturing of pharmaceuticals; custom manufacture of pharmaceuticals; manufacture, processing and production of recombinant proteins for use in the biotechnology industries to the order and specification of others; cell culture manufacturing services for others; custom manufacture of biologics; information, advice and consultancy in relation to all the aforesaid. Construction services; building services; construction of pharmaceutical facilities; onsite management relating to the construction of pharmaceutical manufacturing facilities; building and construction of factories; custom construction of factories and pharmaceutical manufacturing facilities; information, advice and consultancy in relation to all the aforesaid. Scientific and technological services; research and development; scientific, industrial and technical research, development and analysis services; scientific, industrial and technical research, development and analysis services in the field of biotechnology; industrial process development; development of processes for the use in the manufacture of biotechnology products; technical project studies; biotechnology testing; research and consultancy in the field of biotechnology; research and development in the pharmaceutical and biotechnology industry; scientific, technological and pharmaceutical process development and design; biopharmaceutical product development; software development, programming and implementation; design and development of software; design and development of manufacturing processes in the field of biopharmaceuticals; design of manufacturing methods; design of industrial buildings; design of manufacturing plants; engineering services; research laboratories; preparations of biological samples for analysis in research laboratories; designs services relating to process systems for the biotechnology industry; design services relating to plant for the biotechnology industry; information, advice and consultancy in relation to all the aforesaid.
16.
SEQUENCES AND METHODS FOR PRODUCTION OF RECOMBINANT BIOLOGICAL MOLECULES IN VESICLES
FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (Royaume‑Uni)
Inventeur(s)
Mulvihill, Daniel
Baker, Karen
Eastwood, Tara
Lennon, Christopher
Abrégé
Described is a method and component parts of a recombinant expression system for the expression of a biological molecule. In particular, an isolated vesicle nucleating polypeptide (VNp) comprising an amphipathic alpha helix polypeptide derived from the amino terminus of synuclein isoforms and variants thereof is used to promote, enhance or increase the formation of vesicles in the expression system to enable purification of the biological molecule.
C07K 14/47 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'animauxPeptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'humains provenant de vertébrés provenant de mammifères
FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (Royaume‑Uni)
Inventeur(s)
Mulvihill, Daniel
Baker, Karen
Eastwood, Tara
Lennon, Christopher
Abrégé
Described is a method and component parts of a recombinant expression system for the expression of a biological molecule. In particular, an isolated vesicle nucleating polypeptide (VNp) comprising an amphipathic alpha helix polypeptide derived from the amino terminus of synuclein isoforms and variants thereof is used to promote, enhance or increase the formation of vesicles in the expression system to enable purification of the biological molecule.
C07K 14/47 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'animauxPeptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'humains provenant de vertébrés provenant de mammifères
Fujifilm Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Inventeur(s)
Nagy, Tibor
Haigh, Jonathan
Heise, Charles
Topping, Andrew
Pullen, James
Abrégé
A process for purifying a composition comprising water, a target substance, impurities and optionally cells, the process comprising the steps (A) and (B):
(A) preparing a liquid feedstock by performing step (Ai) and/or (Aii) on the composition:
(Ai) removing at least some of the cells from the composition;
(Aii) concentrating the composition by removing water therefrom; and
(B) passing the liquid feedstock through an apparatus comprising at least two processing units, each such unit producing a product stream containing purified target substance and optionally a waste stream comprising at least some of the impurities, wherein each unit comprises specified components (i) to (v). The units may be essentially the same except for a device they contain, leading to advantages in terms of simplicity, cost and ease of operation, lower risk of operator error, easier maintenance and lower inventory of spare parts.
B01D 15/38 - Adsorption sélective, p. ex. chromatographie caractérisée par le mécanisme de séparation impliquant une interaction spécifique non couverte par un ou plusieurs des groupes , p. ex. chromatographie d'affinité, chromatographie d'échange par ligand ou chromatographie chirale
B01D 15/36 - Adsorption sélective, p. ex. chromatographie caractérisée par le mécanisme de séparation impliquant une interaction ionique, p. ex. échange d'ions, paire d'ions, suppression d'ions ou exclusion d'ions
B01D 15/18 - Adsorption sélective, p. ex. chromatographie caractérisée par des caractéristiques de structure ou de fonctionnement relatives aux différents types d'écoulement
C12M 1/34 - Mesure ou test par des moyens de mesure ou de détection des conditions du milieu, p. ex. par des compteurs de colonies
19.
Apparatus for Purifying a Liquid Comprising a Target Substance
Fujifilm Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Inventeur(s)
Nagy, Tibor
Haigh, Jonathan
Heise, Charles
Topping, Andrew
Pullen, James
Abrégé
Apparatus for purifying a liquid comprising a target substance comprising at least two units arranged in series such that the feed stream of the second and any subsequent units comprises the product stream from a downstream unit, wherein each unit comprises specified components (i) to (vi), including a a switchable bypass assembly. Also claimed are the units and a flowpath assembly. The units may be essentially the same except for a device they contain, leading to advantages in terms of simplicity, cost and ease of operation, lower risk of operator error, easier maintenance and lower inventory of spare parts.
C12M 1/00 - Appareillage pour l'enzymologie ou la microbiologie
B01D 15/18 - Adsorption sélective, p. ex. chromatographie caractérisée par des caractéristiques de structure ou de fonctionnement relatives aux différents types d'écoulement
B01D 15/16 - Adsorption sélective, p. ex. chromatographie caractérisée par des caractéristiques de structure ou de fonctionnement relatives au conditionnement du fluide vecteur
C07K 1/16 - ExtractionSéparationPurification par chromatographie
Fujifilm Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Inventeur(s)
Nagy, Tibor
Haigh, Jonathan
Heise, Charles
Topping, Andrew
Pullen, James
Abrégé
A process for purifying a liquid feedstock comprising a monoclonal antibody and impurities, the process comprising passing the liquid feedstock through an apparatus comprising at least two processing units, each such unit producing a product stream containing purified monoclonal antibody and optionally a waste stream comprising at least some of the impurities, wherein each unit comprises specified components (i) to (v) which include a multiple inlet flow-controller comprising two or more variable flow inlet valves for in situ production of a bioprocessing liquid by combining at least two liquids in a desired ratio. One of the units performs chromatography and another performs viral inactivation. The units may be essentially the same except for a device they contain, leading to advantages in terms of simplicity, cost and ease of operation, lower risk of operator error, easier maintenance and lower inventory of spare parts.
C07K 16/06 - Immunoglobulines, p. ex. anticorps monoclonaux ou polyclonaux provenant de sérum
B01D 15/14 - Adsorption sélective, p. ex. chromatographie caractérisée par des caractéristiques de structure ou de fonctionnement relatives à l'introduction de l'alimentation dans l'appareil
B01D 15/18 - Adsorption sélective, p. ex. chromatographie caractérisée par des caractéristiques de structure ou de fonctionnement relatives aux différents types d'écoulement
B01D 15/38 - Adsorption sélective, p. ex. chromatographie caractérisée par le mécanisme de séparation impliquant une interaction spécifique non couverte par un ou plusieurs des groupes , p. ex. chromatographie d'affinité, chromatographie d'échange par ligand ou chromatographie chirale
B01D 15/36 - Adsorption sélective, p. ex. chromatographie caractérisée par le mécanisme de séparation impliquant une interaction ionique, p. ex. échange d'ions, paire d'ions, suppression d'ions ou exclusion d'ions
Fujifilm Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Inventeur(s)
Saunders, Fay Louise
Dodds, Anna Louise
Bayard, Adeline Marie Geraldine
Kara, Bhupendra Vallabh
Abrégé
A process for the production of a target polypeptide is provided. The process comprises expression of an expression vector for expressing a target polypeptide in a host cell, preferably a mammalian cell, the expression vector comprising an expression cassette comprising a polynucleotide encoding a recombinant polypeptide operably linked to a fibronectin secretion leader sequence; and recovering the target polypeptide.
C12N 15/85 - Vecteurs ou systèmes d'expression spécialement adaptés aux hôtes eucaryotes pour cellules animales
C07K 16/06 - Immunoglobulines, p. ex. anticorps monoclonaux ou polyclonaux provenant de sérum
C07K 16/30 - Immunoglobulines, p. ex. anticorps monoclonaux ou polyclonaux contre du matériel provenant d'animaux ou d'humains contre des récepteurs, des antigènes de surface cellulaire ou des déterminants de surface cellulaire provenant de cellules de tumeurs
40 - Traitement de matériaux; recyclage, purification de l'air et traitement de l'eau
42 - Services scientifiques, technologiques et industriels, recherche et conception
Produits et services
Continuous production, including continuous manufacture and
purification, of biological products such as cells, viruses
and biomolecules, including genes and proteins, obtained
from recombinant cells, to the order and specification of
others; continuous expression, isolation and purification,
of biological products such as cells, viruses and
biomolecules, including genes and proteins, obtained from
recombinant cells, to the order and specification of others;
continuous connected upstream and downstream production of
biological products such as cells, viruses and biomolecules,
including genes and proteins, obtained from recombinant
cells, to the order and specification of others. Scientific, industrial and technical research, development
and analysis services related to continuous production,
including continuous manufacture and purification, of
biological products such as such as cells, viruses and
biomolecules, including genes and proteins, obtained from
recombinant cells; process development related to the
continuous production, including continuous manufacture and
purification, of biological products such as such as cells,
viruses and biomolecules, including genes and proteins,
obtained from recombinant cells; industrial design services
related to the continuous production, including continuous
manufacture and purification, of biological products such as
such as cells, viruses and biomolecules, including genes and
proteins, obtained from recombinant cells; provision of
facilities for scientific, industrial and technical research
development related to the continuous production, including
continuous manufacture and purification, of biological
products such as such as cells, viruses and biomolecules,
including genes and proteins, obtained from recombinant
cells.
Fujifilm Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Inventeur(s)
Heise, Charles
Abrégé
A static mixing apparatus for mixing a fluid, preferably a liquid is provided. The mixer comprises a plurality of chambers (5, 8, 12, 15) in series, the first chamber (5) of the series comprising a fluid inlet (4), and the final chamber (15) of the series comprising a fluid outlet (16), each chamber other than the final chamber in the series being in fluid connection with a subsequent chamber, the fluid connection comprising a plurality of orifices (7, 10, 11, 14) dispersed along a direction of flow, the nearest point to the fluid inlet of each subsequent orifice to the inlet overlapping with the furthest point from the fluid inlet of the previous orifice, and being off-set along the direction of flow from the previous orifice.
Fujifilm Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Inventeur(s)
Heise, Charles
Nagy, Tibor
Abrégé
A method of concentration of a liquid comprising a biomolecule is provided. The method comprises passing the liquid through a tangential flow filtration device under pressure, wherein the pressure applied is varied between at least a higher pressure and a lower pressure. Preferably, the variation in pressure is delivered by the use of a variable flow-controller, such as a valve.
FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (Royaume‑Uni)
Inventeur(s)
Nagy, Tibor
Haigh, Jonathan
Heise, Charles
Topping, Andrew
Pullen, James
Abrégé
Apparatus for purifying a liquid comprising a target substance comprising at least two units arranged in series such that the feed stream of the second and any subsequent units comprises the product stream from a downstream unit, wherein each unit comprises specified components (i) to (vi), including a a switchable bypass assembly. Also claimed are the units and a flowpath assembly. The units may be essentially the same except for a device they contain, leading to advantages in terms of simplicity, cost and ease of operation, lower risk of operator error, easier maintenance and lower inventory of spare parts.
B01D 15/18 - Adsorption sélective, p. ex. chromatographie caractérisée par des caractéristiques de structure ou de fonctionnement relatives aux différents types d'écoulement
C12N 15/10 - Procédés pour l'isolement, la préparation ou la purification d'ADN ou d'ARN
B01D 15/16 - Adsorption sélective, p. ex. chromatographie caractérisée par des caractéristiques de structure ou de fonctionnement relatives au conditionnement du fluide vecteur
C12M 1/00 - Appareillage pour l'enzymologie ou la microbiologie
FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (Royaume‑Uni)
Inventeur(s)
Nagy, Tibor
Haigh, Jonathan
Heise, Charles
Topping, Andrew
Pullen, James
Abrégé
in situin situ production of a bioprocessing liquid by combining at least two liquids in a desired ratio. One of the units performs chromatography and another performs viral inactivation. The units may be essentially the same except for a device they contain, leading to advantages in terms of simplicity, cost and ease of operation, lower risk of operator error, easier maintenance and lower inventory of spare parts.
G01N 30/34 - Contrôle des paramètres physiques du fluide vecteur de la composition du fluide, p. ex. du gradient
B01D 15/36 - Adsorption sélective, p. ex. chromatographie caractérisée par le mécanisme de séparation impliquant une interaction ionique, p. ex. échange d'ions, paire d'ions, suppression d'ions ou exclusion d'ions
B01D 15/38 - Adsorption sélective, p. ex. chromatographie caractérisée par le mécanisme de séparation impliquant une interaction spécifique non couverte par un ou plusieurs des groupes , p. ex. chromatographie d'affinité, chromatographie d'échange par ligand ou chromatographie chirale
C07K 1/16 - ExtractionSéparationPurification par chromatographie
C07K 1/36 - ExtractionSéparationPurification par une combinaison de plusieurs procédés de types différents
C12N 7/04 - Inactivation ou atténuationProduction de parties élémentaires de virus
C12N 15/10 - Procédés pour l'isolement, la préparation ou la purification d'ADN ou d'ARN
FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (Royaume‑Uni)
Inventeur(s)
Nagy, Tibor
Haigh, Jonathan
Heise, Charles
Topping, Andrew
Pullen, James
Abrégé
A process for purifying a composition comprising water, a target substance, impurities and optionally cells, the process comprising the steps (A) and (B): (A) preparing a liquid feedstock by performing step (Ai) and/or (Aii) on the composition: (Ai) removing at least some of the cells from the composition; (Aii) concentrating the composition by removing water therefrom; and (B) passing the liquid feedstock through an apparatus comprising at least two processing units, each such unit producing a product stream containing purified target substance and optionally a waste stream comprising at least some of the impurities, wherein each unit comprises specified components (i) to (v). The units may be essentially the same except for a device they contain, leading to advantages in terms of simplicity, cost and ease of operation, lower risk of operator error, easier maintenance and lower inventory of spare parts.
B01D 15/18 - Adsorption sélective, p. ex. chromatographie caractérisée par des caractéristiques de structure ou de fonctionnement relatives aux différents types d'écoulement
C07K 1/36 - ExtractionSéparationPurification par une combinaison de plusieurs procédés de types différents
C12M 1/00 - Appareillage pour l'enzymologie ou la microbiologie
C12N 15/10 - Procédés pour l'isolement, la préparation ou la purification d'ADN ou d'ARN
G01N 30/34 - Contrôle des paramètres physiques du fluide vecteur de la composition du fluide, p. ex. du gradient
G01N 30/46 - Modèles d'écoulement utilisant plus d'une colonne
B01D 15/16 - Adsorption sélective, p. ex. chromatographie caractérisée par des caractéristiques de structure ou de fonctionnement relatives au conditionnement du fluide vecteur
28.
APPARATUS FOR PURIFYING A LIQUID COMPRISING A TARGET SUBSTANCE
FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (Royaume‑Uni)
Inventeur(s)
Nagy, Tibor
Haigh, Jonathan
Heise, Charles
Topping, Andrew
Pullen, James
Abrégé
Apparatus for purifying a liquid comprising a target substance comprising at least two units arranged in series such that the feed stream of the second and any subsequent units comprises the product stream from a downstream unit, wherein each unit comprises specified components (i) to (vi), including a a switchable bypass assembly. Also claimed are the units and a flowpath assembly. The units may be essentially the same except for a device they contain, leading to advantages in terms of simplicity, cost and ease of operation, lower risk of operator error, easier maintenance and lower inventory of spare parts.
G01N 30/34 - Contrôle des paramètres physiques du fluide vecteur de la composition du fluide, p. ex. du gradient
G01N 30/46 - Modèles d'écoulement utilisant plus d'une colonne
C07K 1/36 - ExtractionSéparationPurification par une combinaison de plusieurs procédés de types différents
C12N 15/10 - Procédés pour l'isolement, la préparation ou la purification d'ADN ou d'ARN
B01D 15/18 - Adsorption sélective, p. ex. chromatographie caractérisée par des caractéristiques de structure ou de fonctionnement relatives aux différents types d'écoulement
C12M 1/00 - Appareillage pour l'enzymologie ou la microbiologie
B01D 15/16 - Adsorption sélective, p. ex. chromatographie caractérisée par des caractéristiques de structure ou de fonctionnement relatives au conditionnement du fluide vecteur
29.
Apparatus for processing a liquid comprising a target substance
Fujifilm Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Inventeur(s)
Heise, Charles
Haigh, Jonathan
Nagy, Tibor
Pullen, James
Topping, Andrew
Abrégé
Apparatus for processing a liquid comprising a target substance, preferably a biomolecule, is provided. The apparatus comprises at least a first and a second means for carrying out a unit operation, each means for carrying out a unit operation comprising a feed for a liquid in fluid connection with the inlet of a flow-controller comprising a variable flow inlet valve and an outlet, wherein at least one of the means for carrying out a unit operation comprises feeds for at least two liquids, the feeds being in fluid connection with the inlets of a multiple inlet flow-controller comprising two or more variable flow inlet valves for dosing the at least two liquids, the flow-controller also comprising an outlet; a feed for a liquid feedstock comprising the target substance in fluid connection with the outlet from the flow-controller thereby to enable combination of the feed for a liquid comprising the target substance with the mixed bioprocessing liquids to produce a device feed; a device for achieving a processing operation comprising a device inlet and a device outlet, the device inlet being in fluid connection with the device feed; and a means for imparting flow through the flow controller and from the feed for the liquid feedstock through the processing device via the device inlet; and wherein the feed for a liquid feedstock comprising the target substance for the second means for carrying out a unit operation comprises the outlet from the first means for carrying out a unit operation.
09 - Appareils et instruments scientifiques et électriques
11 - Appareils de contrôle de l'environnement
40 - Traitement de matériaux; recyclage, purification de l'air et traitement de l'eau
42 - Services scientifiques, technologiques et industriels, recherche et conception
Produits et services
Apparatus for use in separation and purification, including
separation and purification of biological products such as
cells, viruses and biomolecules, including genes and
proteins; liquid chromatography apparatus for laboratory or
scientific use; ion exchange apparatus for laboratory or
scientific use; ultrafiltration apparatus for laboratory or
scientific use; diafiltration apparatus for laboratory or
scientific use; apparatus for diluting or concentrating
biological products for laboratory or scientific use;
apparatus for removal of viruses from solutions, including
biological products, for laboratory or scientific use;
apparatus for inactivation of viruses from solutions for
laboratory or scientific use; apparatus for membrane
filtration for laboratory or scientific use; apparatus for
performing chromatographic separations and parts thereof for
laboratory or scientific use; flowpaths, parts and fittings,
including tubing, valves, in-line mixers, pressure sensors,
temperature sensors and/or other sensors for all the
aforesaid goods; computer software for control of the
aforesaid goods; computer software for management of
biological product purification processes. Apparatus for use in separation and purification for
industrial purposes, including separation and purification
of biological products such as cells, viruses and
biomolecules, including genes and proteins; liquid
chromatography apparatus for industrial purposes; ion
exchange apparatus for industrial purposes; ultrafiltration
apparatus for industrial purposes; diafiltration apparatus
for industrial purposes; apparatus for diluting or
concentrating biological products for industrial purposes;
apparatus for removal of viruses from solutions, including
biological products for industrial purposes; apparatus for
inactivation of viruses from solutions for industrial
purposes; apparatus for membrane filtration for industrial
purposes; apparatus for performing chromatographic
separations and parts thereof for industrial purposes;
flowpaths, parts and fittings, including tubing, valves,
in-line mixers, pressure sensors, temperature sensors and/or
other sensors for all the aforesaid goods. Processing and manufacturing of biological products such as
cells, viruses and biomolecules, including genes and
proteins, including to the order and specification of
others; manufacture, processing and production of
biomolecules such as cells, viruses and biomolecules,
including genes and proteins, to the order and specification
of others. Scientific, industrial and technical research, development
and analysis services related to biological products such as
such as cells, viruses and biomolecules, including genes and
proteins; process development related to the manufacture and
purification of biological products such as such as cells,
viruses and biomolecules, including genes and proteins;
industrial design services related to the manufacture and
purification of biological products such as such as cells,
viruses and biomolecules, including genes and proteins;
provision of facilities for scientific, industrial and
technical research development related to the manufacture
and purification of biological products such as such as
cells, viruses and biomolecules, including genes and
proteins.
Fujifilm Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Inventeur(s)
Lennon, Christopher
Abrégé
A protein expression system for use in a prokaryotic host is provided, the expression system comprising: a) an expression cassette comprising a nucleic acid sequence encoding a protein of interest operably linked to a T7 RNA polymerase-dependent promoter; and b) an expression cassette comprising a nucleic acid sequence encoding T7 RNA polymerase operably linked to a host polymerase-dependent λ phage promoter and a single perfect palindrome operator sequence; wherein the expression cassette for T7 RNA polymerase is located on the chromosome of a host cell.
40 - Traitement de matériaux; recyclage, purification de l'air et traitement de l'eau
42 - Services scientifiques, technologiques et industriels, recherche et conception
Produits et services
Continuous, custom production or manufacture, namely continuous extraction, and purification, of biological products in the nature of cells, viruses and biomolecules, genes and proteins, obtained from recombinant cells, to the order and specification of others; Continuous, custom manufacture, namely continuous expression isolation, and purification, of biological products in the nature of cells, viruses and biomolecules, genes and proteins, obtained from recombinant cells, to the order and specification of others; Continuous, custom production or manufacture, namely, continuous connected upstream and downstream manufacture of biological products in the nature of cells, viruses and biomolecules, genes and proteins, obtained from recombinant cells, to the order and specification of others Scientific, industrial and technical research, development and analysis services related to continuous production, continuous manufacture and purification, of biological products in the nature of cells, viruses and biomolecules, genes and proteins, obtained from recombinant cells; Scientific research and development, namely process development related to the continuous production, continuous manufacture and purification, of biological products in the nature of cells, viruses and biomolecules, genes and proteins, obtained from recombinant cells; Industrial design services related to the continuous production, continuous manufacture and purification, of biological in the nature of cells, viruses and biomolecules, genes and proteins, obtained from recombinant cells; Provision of facilities for scientific, industrial and technical research development related to the continuous production, continuous manufacture and purification, of biological products in the nature of cells, viruses and biomolecules, genes and proteins, obtained from recombinant cells
Fujifilm Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Inventeur(s)
Heise, Charles
Nagy, Tibor
Abrégé
Apparatus for in-line liquid exchanging a biomolecule-containing liquid is provided. The apparatus comprises a means for mixing at least two liquids comprising a multiple inlet flow-controller, the means for mixing also comprising an outlet in fluid connection with a tangential flow filtration device configured in single-pass mode.
Fujifilm Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Inventeur(s)
Nagy, Tibor
Abrégé
A method for preparing an aqueous solution of a defined pH comprising an acid, a base and optionally one or more additives is provided. The method comprises the steps of:
a) calculating the theoretical concentrations of acid and base for the solution to have the defined pH using the Henderson-Hasselbach equation in combination with the Debye Huckel theory for a range of different additive concentrations; b) preparing a sample of the buffer for the range of additive concentrations and measuring the actual pH for each additive concentration; c) calculating a value for delta pH, ΔpH, being the difference between the theoretical pH and the actual pH, for each additive concentration; d) generating a mathematical model describing the relationship of ΔpH with additive concentration; e) selecting the defined pH and additive concentrations; f) using the mathematical model generated in step d) to calculate ΔpH for the defined pH and additive concentration; g) calculating a ΔpH-corrected pH by summing the defined pH and delta pH; h) using the ΔpH-corrected pH to calculate the concentrations of acid and base using the Henderson-Hasselbach equation in combination with the Debye Huckel theory; i) preparing the solution using the concentrations calculated in step h).
B01D 15/16 - Adsorption sélective, p. ex. chromatographie caractérisée par des caractéristiques de structure ou de fonctionnement relatives au conditionnement du fluide vecteur
G01N 30/34 - Contrôle des paramètres physiques du fluide vecteur de la composition du fluide, p. ex. du gradient
G05D 21/02 - Commande des variables chimiques ou physico-chimiques, p. ex. de la valeur du pH caractérisée par l'utilisation de moyens électriques
B01F 25/42 - Mélangeurs statiques dans lesquels le mélange est affecté par le déplacement conjoint des composants dans des directions différentes, p. ex. dans des tubes munis de chicanes ou d'obstructions
B01F 35/221 - Commande ou régulation des paramètres de fonctionnement, p. ex. du niveau de matière dans le mélangeur, de la température ou de la pression
09 - Appareils et instruments scientifiques et électriques
11 - Appareils de contrôle de l'environnement
40 - Traitement de matériaux; recyclage, purification de l'air et traitement de l'eau
42 - Services scientifiques, technologiques et industriels, recherche et conception
Produits et services
Fluid processing system for use in the separation and purification of biological products such as cells, viruses and biomolecules, including nucleic acids and proteins, for bioprocessing and pharmaceutical research, comprised primarily of chromatography apparatus for laboratory use, laboratory filters, and fluid handling devices used for bioprocessing applications and component parts and fittings; Liquid chromatography apparatus for laboratory use; Ion exchange chromatography apparatus for the treatment of fluids for laboratory use; Ultrafiltration apparatus for laboratory or scientific research use, namely, ultrafiltration laboratory filters and laboratory ultrafiltration filter membranes as part of scientific apparatus; Diafiltration apparatus for laboratory or scientific research use, namely, laboratory diafiltration filters; Scientific, laboratory, and measuring apparatus and instruments for diluting or concentrating biological products for laboratory or scientific research use, namely, tangential flow filtration devices for preparation of biological samples for use in the biopharmaceutical industry; Laboratory filters in the nature of viral filtration apparatus for removal of viruses from solutions for laboratory or scientific research use; Membrane filtration apparatus in the nature of membrane laboratory filters for use in laboratory equipment in the biopharmaceutical industry for treating biological fluids and solutions; Chromatography apparatus and component parts thereof for laboratory or scientific research use; Parts and fittings, namely, tubing, valves, in-line mixers, pressure sensors, temperature sensors and electronic sensors specially adapted for use with all of the aforementioned goods; Computer software for control of the aforesaid goods, namely, downloadable and recorded software for operating a fluid processing apparatus for laboratory or scientific research use comprising chromatography, membrane filtration, tangential flow filtration, viral filtration, ultrafiltration, diafiltration, viral filtration, viral inactivation, in-line conditioning, and buffer management components and systems; Computer software for management of biological product purification processes, namely, downloadable and recorded software for managing the purification of cells, viruses, and biomolecules in the nature of nucleic acids and proteins Fluid processing system apparatus and system for use in the separation and purification of biological products such as cells, viruses and biomolecules, including nucleic acids and proteins, for the pharmaceutical and biomanufacturing industries, namely, chromatography apparatus for industrial use and apparatus and instruments for use in the purification, conditioning, separation and sterilization of liquids and gases used in the biotechnology, pharmaceutical, medical, and biopharmaceutical industries; Liquid chromatography apparatus for industrial purposes; Ion exchange apparatus for the treatment of fluids for industrial purposes; Ultrafiltration apparatus for industrial purposes, namely, apparatus and instruments for use in the purification, separation and sterilization of liquids and gases used in the biotechnology, pharmaceutical, medical, and biopharmaceutical industries; Diafiltration apparatus, namely, aqueous solution filtering systems and components and biological fluid filtering systems and components for industrial purposes being apparatus and instruments for use in the purification, separation and sterilization of liquids used in the biotechnology, pharmaceutical, medical, and biopharmaceutical industries; Apparatus for diluting or concentrating biological products for industrial purposes, namely, tangential flow filtration apparatus being apparatus for use in the purification, separation and sterilization of liquids and gases used in the biotechnology, pharmaceutical, medical, and biopharmaceutical industries; Viral filtration apparatus for removal of viruses from solutions for industrial purposes, namely, apparatus and instruments for use in the purification, separation and sterilization of liquids and gases used in the biotechnology, pharmaceutical, medical, and biopharmaceutical industries; Virus inactivation and disinfection apparatus for the treatment of biological products in the field of biomanufacturing and pharmaceuticals, all for industrial purposes in the nature of apparatus and instruments for use in the purification, separation and sterilization of liquids and gases used in the biotechnology, pharmaceutical, medical, and biopharmaceutical industries; Membrane filtration apparatus for industrial purposes in the nature of membrane filter cartridges for the separation of biomolecules in biopharmaceutical production; Chromatography apparatus for industrial purposes and component parts thereof; Parts and fittings, namely, tubing, valves, in-line mixers, pressure sensors, temperature sensors and electric sensors, specially adapted for use with the aforementioned Processing and manufacturing of biological products such as cells, viruses and biomolecules, including genes and proteins, namely, manufacturing of pharmaceuticals using biological organisms in the manufacturing process to the order and specification of others; Manufacture of biomolecules such as cells, viruses and biomolecules, including genes and proteins, to the order and specification of others Scientific research, industrial biomedical research and technical product research and development services in the field of biomanufacturing, bioprocessing and pharmaceuticals related to biological products such as cells, viruses and biomolecules, including nucleic acids and proteins; Process development services related to the manufacture and purification of biological products such as such as cells, viruses and biomolecules, including nucleic acids and proteins, namely, biomedical and pharmaceutical research; Industrial design services related to the manufacture and purification of biological products such as cells, viruses and biomolecules, including nucleic acids and proteins; Provision of facilities for scientific, industrial and technical research and development in the field of biomanufacturing, bioprocessing and pharmaceuticals, namely, scientific laboratory services
FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (Royaume‑Uni)
Inventeur(s)
Heise, Charles
Abrégé
A static mixing apparatus for mixing a fluid, preferably a liquid is provided. The mixer comprises a plurality of chambers (5, 8, 12, 15) in series, the first chamber (5) of the series comprising a fluid inlet (4), and the final chamber (15) of the series comprising a fluid outlet (16), each chamber other than the final chamber in the series being in fluid connection with a subsequent chamber, the fluid connection comprising a plurality of orifices (7, 10, 11, 14) dispersed along a direction of flow, the nearest point to the fluid inlet of each subsequent orifice to the inlet overlapping with the furthest point from the fluid inlet of the previous orifice, and being off-set along the direction of flow from the previous orifice.
FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (Royaume‑Uni)
Inventeur(s)
Heise, Charles
Haigh, Jonathan
Nagy, Tibor
Pullen, James
Topping, Andrew
Abrégé
Apparatus for processing a liquid comprising a target substance, preferably a biomolecule, is provided. The apparatus comprises at least a first and a second means for carrying out a unit operation, each means for carrying out a unit operation comprising a feed for a liquid in fluid connection with the inlet of a flow-controller comprising a variable flow inlet valve and an outlet, wherein at least one of the means for carrying out a unit operation comprises feeds for at least two liquids, the feeds being in fluid connection with the inlets of a multiple inlet flow-controller comprising two or more variable flow inlet valves for dosing the at least two liquids, the flow-controller also comprising an outlet; a feed for a liquid feedstock comprising the target substance in fluid connection with the outlet from the flow-controller thereby to enable combination of the feed for a liquid comprising the target substance with the mixed bioprocessing liquids to produce a device feed; a device for achieving a processing operation comprising a device inlet and a device outlet, the device inlet being in fluid connection with the device feed; and a means for imparting flow through the flow controller and from the feed for the liquid feedstock through the processing device via the device inlet; and wherein the feed for a liquid feedstock comprising the target substance for the second means for carrying out a unit operation comprises the outlet from the first means for carrying out a unit operation.
FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (Royaume‑Uni)
Inventeur(s)
Heise, Charles
Haigh, Jonathan
Nagy, Tibor
Pullen, James
Topping, Andrew
Abrégé
Apparatus for processing a liquid comprising a target substance, preferably a biomolecule, is provided. The apparatus comprises at least a first and a second means for carrying out a unit operation, each means for carrying out a unit operation comprising a feed for a liquid in fluid connection with the inlet of a flow-controller comprising a variable flow inlet valve and an outlet, wherein at least one of the means for carrying out a unit operation comprises feeds for at least two liquids, the feeds being in fluid connection with the inlets of a multiple inlet flow-controller comprising two or more variable flow inlet valves for dosing the at least two liquids, the flow-controller also comprising an outlet; a feed for a liquid feedstock comprising the target substance in fluid connection with the outlet from the flow-controller thereby to enable combination of the feed for a liquid comprising the target substance with the mixed bioprocessing liquids to produce a device feed; a device for achieving a processing operation comprising a device inlet and a device outlet, the device inlet being in fluid connection with the device feed; and a means for imparting flow through the flow controller and from the feed for the liquid feedstock through the processing device via the device inlet; and wherein the feed for a liquid feedstock comprising the target substance for the second means for carrying out a unit operation comprises the outlet from the first means for carrying out a unit operation.
FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (Royaume‑Uni)
Inventeur(s)
Nagy, Tibor
Abrégé
A method for preparing an aqueous solution of a defined pH comprising an acid, a base and optionally one or more additives is provided. The method comprises the steps of: a) calculating the theoretical concentrations of acid and base for the solution to have the defined pH using the Henderson-Hasselbach equation in combination with the Debye Huckel theory for a range of different additive concentrations; b) preparing a sample of the buffer for the range of additive concentrations and measuring the actual pH for each additive concentration; c) calculating a value for delta pH, ?pH, being the difference between the theoretical pH and the actual pH, for each additive concentration; d) generating a mathematical model describing the relationship of ?pH with additive concentration; e) selecting the defined pH and additive concentrations;f) using the mathematical model generated in step d) to calculate ?pH for the defined pH and additive concentration; g) calculating a ?pH-corrected pH by summing the defined pH and delta pH; h) using the ?pH-corrected pH to calculate the concentrations of acid and base using the Henderson-Hasselbach equation in combination with the Debye Huckel theory; i) preparing the solution using the concentrations calculated in step h).
G01N 30/34 - Contrôle des paramètres physiques du fluide vecteur de la composition du fluide, p. ex. du gradient
B01J 47/15 - Commande ou régulation pour l’obtention d’une solution ayant un pH fixe
B01D 15/16 - Adsorption sélective, p. ex. chromatographie caractérisée par des caractéristiques de structure ou de fonctionnement relatives au conditionnement du fluide vecteur
G05D 21/02 - Commande des variables chimiques ou physico-chimiques, p. ex. de la valeur du pH caractérisée par l'utilisation de moyens électriques
40.
METHOD FOR PREPARING AQUEOUS SOLUTIONS OF A DEFINED PH
FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (Royaume‑Uni)
Inventeur(s)
Nagy, Tibor
Abrégé
A method for preparing an aqueous solution of a defined pH comprising an acid, a base and optionally one or more additives is provided. The method comprises the steps of: a) calculating the theoretical concentrations of acid and base for the solution to have the defined pH using the Henderson-Hasselbach equation in combination with the Debye Huckel theory for a range of different additive concentrations; b) preparing a sample of the buffer for the range of additive concentrations and measuring the actual pH for each additive concentration; c) calculating a value for delta pH, ∆pH, being the difference between the theoretical pH and the actual pH, for each additive concentration; d) generating a mathematical model describing the relationship of ∆pH with additive concentration; e) selecting the defined pH and additive concentrations;f) using the mathematical model generated in step d) to calculate ∆pH for the defined pH and additive concentration; g) calculating a ∆pH-corrected pH by summing the defined pH and delta pH; h) using the ∆pH-corrected pH to calculate the concentrations of acid and base using the Henderson-Hasselbach equation in combination with the Debye Huckel theory; i) preparing the solution using the concentrations calculated in step h).
G01N 30/34 - Contrôle des paramètres physiques du fluide vecteur de la composition du fluide, p. ex. du gradient
G05D 21/02 - Commande des variables chimiques ou physico-chimiques, p. ex. de la valeur du pH caractérisée par l'utilisation de moyens électriques
B01J 47/15 - Commande ou régulation pour l’obtention d’une solution ayant un pH fixe
B01D 15/16 - Adsorption sélective, p. ex. chromatographie caractérisée par des caractéristiques de structure ou de fonctionnement relatives au conditionnement du fluide vecteur
41.
Tangential flow filtration process for concentrating biomolecule solutions
Fujifilm Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Inventeur(s)
Heise, Charles
Nagy, Tibor
Abrégé
A method of concentration of a liquid comprising a biomolecule is provided. The method comprises passing the liquid through a tangential flow filtration device under pressure, wherein the pressure applied is varied between at least a higher pressure and a lower pressure. Preferably, the variation in pressure is delivered by the use of a variable flow-controller, such as a valve.
Fujifilm Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Inventeur(s)
Heise, Charles
Nagy, Tibor
Abrégé
Apparatus for in-line liquid exchanging a biomolecule-containing liquid is provided. The apparatus comprises a means (3) for mixing at least two liquids comprising a multiple inlet flow-controller (2), the means for mixing also comprising an outlet in fluid connection with a tangential flow filtration device (1) configured in single-pass mode.
01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
40 - Traitement de matériaux; recyclage, purification de l'air et traitement de l'eau
42 - Services scientifiques, technologiques et industriels, recherche et conception
Produits et services
Cell cultures used in industry and science; mammalian cell
cultures and vectors, being independent replicating pieces
of DNA that can transfer DNA sequences, each for manufacture
and development in the biotechnology industries. Processing and manufacturing of vectors, cell cultures and
recombinant proteins for use in biotechnology industries to
the order and specification of others; manufacture,
processing and production of recombinant proteins for use in
the biotechnology industries to the order and specification
of others. Scientific, industrial and technical research, development
and analysis services relating to the use of mammalian cell
cultures and vectors in the field of biotechnology; process
development, namely, development of processes for the use of
mammalian cell cultures and vectors in the manufacture of
biotechnology products; project studies relating to the use
of mammalian cell cultures and vectors in the field of
biotechnology.
FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (Royaume‑Uni)
Inventeur(s)
Lennon, Christopher
Abrégé
A protein expression system for use in a prokaryotic host is provided, the expression system comprising: a) an expression cassette comprising a nucleic acid sequence encoding a protein of interest operably linked to a T7 RNA polymerase-dependent promoter; and b) an expression cassette comprising a nucleic acid sequence encoding T7 RNA polymerase operably linked to a host polymerase-dependent λ phage promoter and a single perfect palindrome operator sequence; wherein the expression cassette for T7 RNA polymerase is located on the chromosome of a host cell.
Fujifilm Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Inventeur(s)
Saunders, Fay Louise
Dodds, Anna Louise
Bayard, Adeline Marie Geraldine
Kara, Bhupendra Vallabh
Abrégé
A process for the production of a target polypeptide is provided. The process comprises expression of an expression vector for expressing a target polypeptide in a host cell, preferably a mammalian cell, the expression vector comprising an expression cassette comprising a polynucleotide encoding a recombinant polypeptide operably linked to a fibronectin secretion leader sequence; and recovering the target polypeptide.
C12N 15/85 - Vecteurs ou systèmes d'expression spécialement adaptés aux hôtes eucaryotes pour cellules animales
C07K 16/06 - Immunoglobulines, p. ex. anticorps monoclonaux ou polyclonaux provenant de sérum
C07K 16/30 - Immunoglobulines, p. ex. anticorps monoclonaux ou polyclonaux contre du matériel provenant d'animaux ou d'humains contre des récepteurs, des antigènes de surface cellulaire ou des déterminants de surface cellulaire provenant de cellules de tumeurs
Fujifilm Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Inventeur(s)
Kara, Bhupendra Vallabh
Lennon, Christopher David John
Hodgson, Ian John
Abrégé
A perfect palindrome operator sequence-based protein expression system is provided. The expression system comprises a promoter; and a perfect palindrome operator sequence, wherein the promoter is not T7. The expression system is preferably employed for the production of recombinant proteins by fermentation.
C12N 15/78 - Vecteurs ou systèmes d'expression spécialement adaptés aux hôtes procaryotes autres que E. coli, p. ex. Lactobacillus, Micromonospora pour Pseudomonas
C12N 15/81 - Vecteurs ou systèmes d'expression spécialement adaptés aux hôtes eucaryotes pour champignons pour levures
C12N 15/85 - Vecteurs ou systèmes d'expression spécialement adaptés aux hôtes eucaryotes pour cellules animales
47.
TANGENTIAL FLOW FILTRATION PROCESS FOR CONCENTRATING BIOMOLECULE SOLUTIONS
FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (Royaume‑Uni)
Inventeur(s)
Heise, Charles
Nagy, Tibor
Abrégé
A method of concentration of a liquid comprising a biomolecule is provided. The method comprises passing the liquid through a tangential flow filtration device under pressure, wherein the pressure applied is varied between at least a higher pressure and a lower pressure. Preferably, the variation in pressure is delivered by the use of a variable flow- controller, such as a valve.
FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (Royaume‑Uni)
Inventeur(s)
Heise, Charles
Nagy, Tibor
Abrégé
Apparatus for in-line liquid exchanging a biomolecule-containing liquid is provided. The apparatus comprises a means (3) for mixing at least two liquids comprising a multiple inlet flow-controller (2), the means for mixing also comprising an outlet in fluid connection with a tangential flow filtration device (1) configured in single-pass mode.
FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (Royaume‑Uni)
Inventeur(s)
Heise, Charles
Nagy, Tibor
Abrégé
A method of concentration of a liquid comprising a biomolecule is provided. The method comprises passing the liquid through a tangential flow filtration device under pressure, wherein the pressure applied is varied between at least a higher pressure and a lower pressure. Preferably, the variation in pressure is delivered by the use of a variable flow- controller, such as a valve.
FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (Royaume‑Uni)
Inventeur(s)
Heise, Charles
Nagy, Tibor
Abrégé
Apparatus for in-line liquid exchanging a biomolecule-containing liquid is provided. The apparatus comprises a means (3) for mixing at least two liquids comprising a multiple inlet flow-controller (2), the means for mixing also comprising an outlet in fluid connection with a tangential flow filtration device (1) configured in single-pass mode.
Fujifilm Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Inventeur(s)
Saunders, Fay Louise
Dodds, Anna Louise
Bayard, Adeline Marie Geraldine
Kara, Bhupendra Vallabh
Abrégé
A process for the production of a target polypeptide is provided. The process comprises expression of an expression vector for expressing a target polypeptide in a host cell, preferably a mammalian cell, the expression vector comprising an expression cassette comprising a polynucleotide encoding a recombinant polypeptide operably linked to a fibronectin secretion leader sequence; and recovering the target polypeptide.
C12N 15/85 - Vecteurs ou systèmes d'expression spécialement adaptés aux hôtes eucaryotes pour cellules animales
C07K 16/06 - Immunoglobulines, p. ex. anticorps monoclonaux ou polyclonaux provenant de sérum
C07K 16/30 - Immunoglobulines, p. ex. anticorps monoclonaux ou polyclonaux contre du matériel provenant d'animaux ou d'humains contre des récepteurs, des antigènes de surface cellulaire ou des déterminants de surface cellulaire provenant de cellules de tumeurs
Fujifilm Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Inventeur(s)
Kara, Bhupendra Vallabh
Lennon, Christopher David John
Abrégé
An expression vector for expressing a target polypeptide in a prokaryotic cell is provided. The vector comprises a promoter operably linked to a polynucleotide encoding the target polypeptide operably linked to a eukaryotic secretion leader sequence, the eukaryotic secretion leader sequence encoding a signal peptide sequence selected from the group consisting of: a) MLKRSSWLATLGLLTVASVSTIVYA; b) MKKATFITCLLAVLLVSNPIWNA; c) MKVSAAALAVILIATALCAPASA; d) MKVSTAFLCLLLTVSAFSAQVLA; and e) MKCLLLALGLALACAAQA. Processes for expressing polypeptides and prokaryotic microorganisms comprising such vectors are also provided.
01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
40 - Traitement de matériaux; recyclage, purification de l'air et traitement de l'eau
42 - Services scientifiques, technologiques et industriels, recherche et conception
Produits et services
Cell cultures used in industry and science; mammalian cell
cultures and vectors, being independent replicating pieces
of DNA that can transfer DNA sequences, each for manufacture
and development in the biotechnology industries. Processing and manufacturing of vectors, cell cultures and
recombinant proteins for use in biotechnology industries to
the order and specification of others; manufacture,
processing and production of recombinant proteins for use in
the biotechnology industries to the order and specification
of others. Scientific, industrial and technical research, development
and analysis services relating to the use of mammalian cell
cultures and vectors in the field of biotechnology; process
development, namely, development of processes for the use of
mammalian cell cultures and vectors in the manufacture of
biotechnology products; project studies relating to the use
of mammalian cell cultures and vectors in the field of
biotechnology.
54.
USE OF METE GENE AS AUXOTROPHIC MARKER IN GENETIC CONSTRUCTS
FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (Royaume‑Uni)
Inventeur(s)
Pointon, Jonathan, Anthony
Abrégé
A process for the production of a target polypeptide is provided. The process comprises expressing an expression cassette for the target recombinant polypeptide comprised in a vector in a non-mammalian host, wherein the host is auxotrophic for methionine and lacks the ability to express functional chromosomal Vitamin B12 independent homocysteine methyltransferase. The vector comprises an expression cassette for functional Vitamin B12 independent homocysteine methyltransferase and the host is cultured in a growth medium lacking methionine.
C12N 15/65 - Introduction de matériel génétique étranger utilisant des vecteursVecteurs Utilisation d'hôtes pour ceux-ciRégulation de l'expression utilisant des marqueurs
FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (Royaume‑Uni)
Inventeur(s)
Saunders, Fay Louise
Abrégé
A DNA construct comprising a hamster beta-actin promoter operably linked to a cytomegalovirus enhancer is provided. Preferably the promoter is Chinese hamster beta- actin promoter, and the enhancer is the hCMV Major Intermediate Early enhancer. The DNA constructs can be employed for the production of polypeptides of interest, especially antibodies and antibody fragments.
FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (Royaume‑Uni)
Inventeur(s)
Lennon, Christopher David John
Abrégé
A process for production of a target recombinant polypeptide in a prokaryotic cell is provided. The process comprises expressing a vector comprising a first expression cassette comprising a polynucleotide encoding the target polypeptide operably linked to an inducible promoter and comprising a ribosome binding site; and a second expression cassette comprising a polynucleotide encoding an sRNA which targets the ribosome binding region of mRNA which corresponds to the ribosome binding site of the first expression cassette, operably linked to a promoter and wherein the sRNA comprises a sequence of bases complementary to at least a part of the ribosome binding region of the mRNA, which sequence comprises at least 8 consecutive bases in which no more than 15% of the bases exhibit non-Watson-Crick nucleotide base pairing to the ribosome binding region of the mRNA.
Fujifilm Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Inventeur(s)
Kara, Bhupendra Vallabh
Lennon, Christopher David John
Abrégé
A process for the production of a target recombinant polypeptide is provided. The process comprises expressing an expression cassette encoding the target polypeptide and co-expressing an expression cassette encoding a mitochondrial foldase. Preferred mitochondrial foldases include Mia 40 and Erv1, and homologs thereof.
FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (Royaume‑Uni)
Inventeur(s)
Saunders, Fay Louise
Dodds, Anna Louise
Bayard, Adeline Marie Geraldine
Kara, Bhupendra Vallabh
Abrégé
A process for the production of a target polypeptide is provided. The process comprises expression of an expression vector for expressing a target polypeptide in a host cell, preferably a mammalian cell, the expression vector comprising an expression cassette comprising a polynucleotide encoding a recombinant polypeptide operably linked to a fibronectin secretion leader sequence; and recovering the target polypeptide.
C12N 15/85 - Vecteurs ou systèmes d'expression spécialement adaptés aux hôtes eucaryotes pour cellules animales
C07K 16/06 - Immunoglobulines, p. ex. anticorps monoclonaux ou polyclonaux provenant de sérum
C07K 16/30 - Immunoglobulines, p. ex. anticorps monoclonaux ou polyclonaux contre du matériel provenant d'animaux ou d'humains contre des récepteurs, des antigènes de surface cellulaire ou des déterminants de surface cellulaire provenant de cellules de tumeurs
FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (Royaume‑Uni)
Inventeur(s)
Saunders, Fay Louise
Dodds, Anna Louise
Bayard, Adeline Marie Geraldine
Kara, Bhupendra Vallabh
Abrégé
A process for the production of a target polypeptide is provided. The process comprises expression of an expression vector for expressing a target polypeptide in a host cell, preferably a mammalian cell, the expression vector comprising an expression cassette comprising a polynucleotide encoding a recombinant polypeptide operably linked to a fibronectin secretion leader sequence; and recovering the target polypeptide.
C12N 15/85 - Vecteurs ou systèmes d'expression spécialement adaptés aux hôtes eucaryotes pour cellules animales
C07K 16/06 - Immunoglobulines, p. ex. anticorps monoclonaux ou polyclonaux provenant de sérum
C07K 16/30 - Immunoglobulines, p. ex. anticorps monoclonaux ou polyclonaux contre du matériel provenant d'animaux ou d'humains contre des récepteurs, des antigènes de surface cellulaire ou des déterminants de surface cellulaire provenant de cellules de tumeurs
40 - Traitement de matériaux; recyclage, purification de l'air et traitement de l'eau
01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
42 - Services scientifiques, technologiques et industriels, recherche et conception
Produits et services
Processing and manufacturing of vectors, cell cultures and recombinant proteins for use in biotechnology industries to the order and specification of others; manufacture, processing and production of recombinant proteins for use in the biotechnology industries to the order and specification of others [ Cell cultures used in industry and science; mammalian cell cultures and vectors, being independent replicating pieces of DNA that can transfer DNA sequences, each for manufacture and development in the biotechnology industries ] Scientific, industrial and technical research, development and analysis services relating to the use of mammalian cell cultures and vectors in the field of biotechnology; process development, namely, development of processes for the use of mammalian cell cultures and vectors in the manufacture of biotechnology products; project studies relating to the use of mammalian cell cultures and vectors in the field of biotechnology
61.
Methylotrophic yeast transformed with gal promoters
Fujifilm Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Inventeur(s)
Kara, Bhupendra Vallabh
Lennon, Christopher David John
Hodgson, Ian John
Abrégé
A perfect palindrome operator sequence-based protein expression system is provided. The expression system comprises a promoter; and a perfect palindrome operator sequence, wherein the promoter is not T7. The expression system is preferably employed for the production of recombinant proteins by fermentation.
C12P 21/00 - Préparation de peptides ou de protéines
C12N 15/70 - Vecteurs ou systèmes d'expression spécialement adaptés à E. coli
C12N 15/72 - Systèmes d'expression utilisant des séquences régulatrices dérivées de l'opéron lac
C12N 15/78 - Vecteurs ou systèmes d'expression spécialement adaptés aux hôtes procaryotes autres que E. coli, p. ex. Lactobacillus, Micromonospora pour Pseudomonas
C12N 15/81 - Vecteurs ou systèmes d'expression spécialement adaptés aux hôtes eucaryotes pour champignons pour levures
C12N 15/85 - Vecteurs ou systèmes d'expression spécialement adaptés aux hôtes eucaryotes pour cellules animales
C12N 15/73 - Systèmes d'expression utilisant des séquences régulatrices du phage lambda
FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (Royaume‑Uni)
Inventeur(s)
Kara, Bhupendra Vallabh
Lennon, Christopher David John
Abrégé
In one aspect, a process for the intracellular expression of CRM197 in an E coli host is provided. The process comprises expressing a vector comprising a gene encoding CRM 197 operably linked to a promoter and at least one perfect palindrome operator sequence. In a related aspect, a process for the periplasmic expression of CRM197 in an E coli host is provided, comprising expressing a vector comprising a gene encoding CRM197 and a secretion leader sequence operably linked to a weak promoter system comprising at least one perfect palindrome operator sequence.
A61K 47/48 - Préparations médicinales caractérisées par les ingrédients non actifs utilisés, p.ex. supports, additifs inertes l'ingrédient non actif étant chimiquement lié à l'ingrédient actif, p.ex. conjugués polymère-médicament
C07K 14/34 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant de bactéries provenant de Corynebacterium (G)
C12N 15/70 - Vecteurs ou systèmes d'expression spécialement adaptés à E. coli
C12N 15/72 - Systèmes d'expression utilisant des séquences régulatrices dérivées de l'opéron lac
C12N 15/73 - Systèmes d'expression utilisant des séquences régulatrices du phage lambda
Fujifilm Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Inventeur(s)
Hodgson, Ian John
Nagy, Tibor
Abrégé
A process for the production of a target recombinant polypeptide is provided. The process comprises expressing a vector comprising a promoter operatively linked to an expression cassette for the target recombinant polypeptide; and a perfect palindrome operator sequence in a culture medium, wherein the culture medium is substantially free from antibiotic.
FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (Royaume‑Uni)
Inventeur(s)
Conradie, Alex Van Eck
Abrégé
A process for the purification of a high-potency polypeptide is provided. The process comprises contacting a crude mixture comprising a high-potency polypeptide and one or more impurities with a purification medium using a supply line; and contacting one or more processing solutions with the purification medium using a supply line, whereby the concentration of one or more impurities relative to the high-potency polypeptide is reduced, characterised in that the supply line for the high potency polypeptide is a disposable supply line separate from the supply line for the processing solutions.
FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (Royaume‑Uni)
Inventeur(s)
Kara, Bhupendra Vallabh
Abrégé
A recombinant yeast of the genus Komagataella which has been transformed with a galactose promoter is provided. The yeast is preferably Komagataella phaffii, and the promoter is preferably a S. cerevisiae GAL1 or GAL10 promoter. Vectors and methods for producing recombinant polypeptides are also provided.
FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (Royaume‑Uni)
Inventeur(s)
Liddell John Macdonald
Razzaq Azam
Abrégé
A process for cell lysis is provided. The process comprises passing a mixture comprising a suspension of cells and a lysis reagent through a flow-through reactor, wherein the mixture passes through the reactor with pulsed or superimposed oscillating flow. The process is preferably employed for the preparation of biological products, such as pDNA or inclusion bodies.
C12N 1/00 - Micro-organismes, p. ex. protozoairesCompositions les contenantProcédés de culture ou de conservation de micro-organismes, ou de compositions les contenantProcédés de préparation ou d'isolement d'une composition contenant un micro-organismeLeurs milieux de culture
FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (Royaume‑Uni)
Inventeur(s)
Hodgson, Ian, John
Nagy, Tibor
Abrégé
A process for the production of a target recombinant polypeptide is provided. The process comprises expressing a vector comprising a promoter operatively linked to an expression cassette for the target recombinant polypeptide; and a perfect palindrome operator sequence in a culture medium, wherein the culture medium is substantially free from antibiotic.
Fujifilm Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Inventeur(s)
Liddell, John Macdonald
Abrégé
A process for the extraction of pDNA from cells is provided. In one aspect, the process comprises heating a liquid comprising the cells to an average temperature of from 95° C. to about 120° C. for a time of less than 10 seconds. In certain preferred aspects, the pDNA is extracted by the use of flow-through apparatus.
C07H 21/00 - Composés contenant au moins deux unités mononucléotide comportant chacune des groupes phosphate ou polyphosphate distincts liés aux radicaux saccharide des groupes nucléoside, p. ex. acides nucléiques
C12N 15/10 - Procédés pour l'isolement, la préparation ou la purification d'ADN ou d'ARN
FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (Royaume‑Uni)
Inventeur(s)
Kara, Bhupendra Vallabh
Lennon, Christopher David John
Abrégé
A process for the production of a target recombinant polypeptide is provided. The process comprises expressing an expression cassette encoding the target polypeptide and co- expressing an expression cassette encoding a mitochondrial foldase. Preferred mitochondrial foldases include Mia 40 and Erv1, and homologs thereof.
Fujifilm Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Inventeur(s)
Liddell, John Macdonald
Abrégé
A process for purification of a fragment antibody from a culture medium also comprising at least one impurity is provided. The purification is carried out after the pH of the culture medium has been reduced to a pH at which the fragment antibody is soluble, but one or more of the impurities are insoluble. A process for the preparation of a fragment antibody employing such a purification process is also provided.
C07K 1/36 - ExtractionSéparationPurification par une combinaison de plusieurs procédés de types différents
C07K 1/30 - ExtractionSéparationPurification par précipitation
C07K 16/06 - Immunoglobulines, p. ex. anticorps monoclonaux ou polyclonaux provenant de sérum
C07K 16/24 - Immunoglobulines, p. ex. anticorps monoclonaux ou polyclonaux contre du matériel provenant d'animaux ou d'humains contre des cytokines, des lymphokines ou des interférons
Fujifilm Diosynth Biotechnologies UK Limited (Royaume‑Uni)
Inventeur(s)
Kara, Bhupendra Vallabh
Lennon, Christopher David John
Abrégé
An expression vector for expressing a target polypeptide in a prokaryotic cell is provided. The vector comprises a promoter operably linked to a polynucleotide encoding the target polypeptide operably linked to a eukaryotic secretion leader sequence, the eukaryotic secretion leader sequence encoding a signal peptide sequence selected from the group consisting of: a) MLKRSSWLATLGLLTVASVSTIVYA; b) MKKATFITCLLAVLLVSNPIWNA; c) MKVSAAALAVILIATALCAPASA; d) MKVSTAFLCLLLTVSAFSAQVLA; and e) MKCLLLALGLALACAAQA. Processes for expressing polypeptides and prokaryotic microorganisms comprising such vectors are also provided.
FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (Royaume‑Uni)
Inventeur(s)
Kara, Bhupendra Vallabh
Abrégé
A process for preparing a conditioned cell culture medium is provided. The process comprises a) culturing eukaryotic cells in a growth medium having a composition effective to support cell growth; b) separating the cultured cells from the growth medium; and c) maintaining the cultured cells in a basal medium having a composition suitable to maintain cell viability, but not to support substantial cell growth. The cells are preferably dermal sheath, dermal papilla or dermal fibroblast cells. The compositions are useful as pharmaceutical compositions, especially for wound healing.
C12N 5/071 - Cellules ou tissus de vertébrés, p. ex. cellules humaines ou tissus humains
A61K 35/36 - PeauSystème pileuxOnglesGlandes sébacéesCérumenÉpidermeCellules épithélialesKératinocytesCellules de LangerhansCellules ectodermiques
A61P 17/02 - Médicaments pour le traitement des troubles dermatologiques pour traiter les blessures, les ulcères, les brûlures, les cicatrices, les cheloïdes, ou similaires
FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (Royaume‑Uni)
Inventeur(s)
Liddell, John Macdonald
Abrégé
A process for the extraction of pDNA from cells is provided. In one aspect, the process comprises heating a liquid comprising the cells to an average temperature of from 95°C to about 120°C for a time of less than 10 seconds. In certain preferred aspects, the pDNA is extracted by the use of flow-through apparatus.
FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (Royaume‑Uni)
Inventeur(s)
Kara, Bhupendra Vallabh
Abrégé
An expression system for the production of a target polypeptide is provided. The expression system comprises an expression cassette comprising an inducible promoter operably linked to DNA encoding the target polypeptide and an expression cassette for over-expression of DNA binding transcriptional regulator protein, comprising a promoter operably linked to DNA encoding the DNA binding transcriptional regulator protein. The expression cassettes are under the control of orthogonal promoters.
C07H 21/04 - Composés contenant au moins deux unités mononucléotide comportant chacune des groupes phosphate ou polyphosphate distincts liés aux radicaux saccharide des groupes nucléoside, p. ex. acides nucléiques avec le désoxyribosyle comme radical saccharide
C12N 15/70 - Vecteurs ou systèmes d'expression spécialement adaptés à E. coli
C12N 1/21 - BactériesLeurs milieux de culture modifiés par l'introduction de matériel génétique étranger
A perfect palindrome operator sequence-based protein expression system is provided. The expression system comprises a promoter; and a perfect palindrome operator sequence, wherein the promoter is not T7. The expression system is preferably employed for the production of recombinant proteins by fermentation.
C12N 1/21 - BactériesLeurs milieux de culture modifiés par l'introduction de matériel génétique étranger
C12N 15/00 - Techniques de mutation ou génie génétiqueADN ou ARN concernant le génie génétique, vecteurs, p. ex. plasmides, ou leur isolement, leur préparation ou leur purificationUtilisation d'hôtes pour ceux-ci
01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
40 - Traitement de matériaux; recyclage, purification de l'air et traitement de l'eau
42 - Services scientifiques, technologiques et industriels, recherche et conception
Produits et services
(Based on 44(e)) [ Microbially produced chemicals used in industry and science; microbial preparations used in industry and science; proteins, enzymes, and cultures of micro organisms used in industry and science; chemical reagents for non-medical purposes; genes being DNA sequences for manufacture and development in the biotechnology and pharmaceutical industries; plasmids being small independently replicating pieces of DNA and vectors being small independent replicating pieces of DNA that can transfer DNA sequences all for manufacture and development in the biotechnology and pharmaceutical industries ] (Based on Use in Commerce) Processing and manufacturing of chemicals and proteins for use in biotechnology and pharmaceutical industries to the order and specification of others; manufacture, processing and production of scientific and industrial products, namely, chemicals and proteins for use in the biotechnology and pharmaceutical industries to the order and specification of others (Based on Use in Commerce) Scientific, industrial and technical research, development and analysis services in the field of biotechnology and pharmaceuticals; process development, namely, development of chemicals for use in the manufacture of biotechnology products and pharmaceuticals; industrial design services; provision of facilities for scientific, industrial and technical research development in the field of biotechnology and pharmaceuticals; research and development of scientific, industrial and technical products; projects studies in the field of biotechnology and pharmaceuticals; testing of scientific, industrial and technical products in the field of biotechnology and pharmaceuticals
01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
40 - Traitement de matériaux; recyclage, purification de l'air et traitement de l'eau
42 - Services scientifiques, technologiques et industriels, recherche et conception
Produits et services
Chemicals used in industry and science; proteins, enzymes; microbial preparations; cultures of micro-organisms; chemical reagents; genes being DNA sequences; plasmids being small independently replicating pieces of DNA and vectors being small independently replicating pieces of DNA that can transfer DNA sequences. Processing and manufacturing of chemicals and proteins, including to the order and specification of others; manufacture, processing and production of scientific and industrial products to the order and specification of others. Scientific, industrial and technical research, development and analysis services; process development; industrial design services; provision of facilities for scientific, industrial and technical research development; research and development of scientific, industrial and technical products; project studies; testing of scientific, industrial and technical products.
FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (Royaume‑Uni)
Inventeur(s)
Hodgson, Ian John
Lennon, Christopher David John
Kara, Bhupendra Vallabh
Abrégé
A protein expression system is provided. The expression system comprises a promoter; and a perfect palindrome operator sequence. In an embodiment, the promoter is T7A1, T7A2, T7A3, .lambda.pL, .lambda.pR, lacUV5, trp, trc, phoA and rrnB. In another embodiment, the promoter is an E. coli polymerase-dependent promoter, and the perfect palindrome operator sequence overlaps with the transcriptional start point. In another embodiment, there is proved a vector comprising a yeast promoter, and a perfect palindrome operator sequence. In another embodiment, there is provided a method for the production of a protein which comprises expressing, in a mammalian cell culture, an expression system comprising: a) a mammalian promoter; and b) two or more perfect palindrome operator sequences, at least one operator sequence being located downstream of the promoter, and at least one operator sequence being located upstream of the promoter; and c) an expression cassette for a recombinant protein.
FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (Royaume‑Uni)
Inventeur(s)
Hodgson, Ian John
Lennon, Christopher David John
Kara, Bhupendra Vallabh
Abrégé
A perfect palindrome operator sequence-based protein expression system is provided. The expression system comprises a promoter; and a perfect palindrome operator sequence, wherein the promoter is not T7. The expression system is preferably employed for the production of recombinant proteins by fermentation.